Introduction
Ankylosing Spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints. It is well-known for its "sexual dimorphism"—it is significantly more common in men (roughly a 3:1 ratio), and the clinical progression varies by gender. Men typically experience more severe spinal fusion and faster radiological progression, while women often present with more peripheral arthritis and a longer delay in diagnosis.
Despite these clear clinical differences, most molecular research into AS has treated patients as a monolithic group. This study addresses the "gender gap" in AS research by investigating whether different gene expression patterns and biological pathways drive the disease in men versus women.
Methodology
The researchers employed a multi-stage "dry-lab to wet-lab" workflow to identify sex-specific drivers of AS:
- Bioinformatics Screening: Analysis of the GSE73754 microarray dataset using GEO2R to identify Differentially Expressed Genes (DEGs), with the analysis split by sex.
- Pathway and Network Analysis: Tools like ClueGO, KEGG, STRING, and Cytoscape were used to identify biological pathways and "hub genes"—highly connected nodes likely driving the disease.
- Experimental Validation: Computational findings were verified using qPCR (mRNA levels) and ELISA (protein levels) on blood and plasma samples from a local patient cohort.
Dataset Analysis
The study utilized a public dataset from the Gene Expression Omnibus (GEO) repository (GSE73754), based on the Illumina humanht-12 V4.0 expression beadchip.
The dataset included a balanced number of male and female AS samples, allowing for a robust comparative analysis of gene expression between the sexes.
Key Findings
Shared Pathways, Different Drivers
Both men and women with AS show significant activity in Th1 and Th2 cell differentiation pathways, which are critical components of the adaptive immune system. However, the specific genetic "keys" that unlock these pathways differ between the sexes.
The "One Gene vs. Two Genes" Hypothesis
The study suggests that male AS pathogenesis is more streamlined, primarily driven by the IL2RB (Interleukin 2 Receptor Subunit Beta) gene. In contrast, female AS appears more complex, requiring the involvement of both IL2RB and CD3D.
- IL2RB: Involved in T-cell mediated immune responses and linked to various autoimmune conditions. Validation showed both mRNA and protein levels were significantly higher in AS patients of both sexes compared to healthy controls (P < 0.05).
- CD3D: Part of the T-cell receptor complex and essential for T-cell activation. Validation confirmed that mRNA and protein levels were significantly higher only in female AS patients. In males, there was no statistically significant difference in CD3D expression between the AS group and the healthy group (P > 0.05).
Conclusion and Future Directions
The identification of distinct genetic signatures—specifically the unique role of CD3D in women—provides a molecular basis for the observed clinical differences in AS. While these findings suggest a path toward personalized treatment, several limitations remain. The experimental validation was performed on a small cohort, and the study relies on microarray technology rather than more sensitive RNA-Seq. Future research should focus on larger clinical cohorts to determine if targeting IL2RB or CD3D specifically can improve outcomes in a gender-dependent manner.
Summary updated